Archive for the 'Lawrence Broxmeyer MD' Category

CWD Tuberculosis Found in Spongiform Disease Formerly Attributed to Prions: Its Implication towards Mad Cow Disease, Scrapie and Alzheimer’s

May 9, 2017


Journal of MPE Molecular Pathological Epidemiology 2017 Vol. 3 No. 3: 3

Lysenko AP PhD,
Broxmeyer L MD,
Vlasenko VV PhD,
Krasochko PA PhD,
Lemish AP and
Krasnikova EL


The TSE’S or transmissible spongiform encephalopathies, include bovine spongiform encephalopathy (also called BSE or “mad cow disease”), Creutzfeldt– Jakob disease (CJD) in humans, and “scrapie” in sheep or goats (caprine spongiform encephalopathy).  They remain a mystery, their cause still hotly debated. Current mad cow diagnosis lies solely in the detection of late appearing “prions”, an acronym for hypothesized, geneless, misfolded proteins, somehow claimed to cause the disease. Yet laboratory preparations of prions contain other things, which could include unidentified bacteria or viruses. And the only real evidence that prion originator Stanley Prusiner had in his original paper that the disease agent behind “Scrapie” in sheep and goats was devoid of DNA or RNA– was based upon the fact that he couldn’t find any. Furthermore, the rigors of prion purification alone, might, in and of themselves, have killed any causative microorganism and Heino Dringer, who did pioneer work on their nature, candidly predicts “it will turn out that the prion concept is wrong.” Roels and Walravens as well as Hartly traced Mad Cow to Mycobacterium bovis. Moreover, epidemiologic maps of the origins and peak incidence of Mad Cow in the UK, suggestively match those of England’s areas of highest bovine tuberculosis, the Southwest. The neurotaxic potential of bovine tuberculosis has for some time been well known. By 1911 Alois Alzheimer called attention to “a characteristic condition of the cortical tissue which Fischer referred to as ‘spongy cortical wasting” in Alzheimer’s disease (AD). But behind AD, Fischer suspected a microbe called Streptothrix which was constantly being mistaken and confused for tuberculosis. Our present investigation of the TSEs clearly shows cell-wall-deficient (CWD) tubercular mycobacteria present, verified by molecular analysis, ELISA, PCR and microscopy to cause spongiform encephalopathy.

Keywords: Prions; Scrapie; The Spongiform Encephalopathies; Alzheimer’s disease; The etiology of Alzheimer’s Disease; Mycobacterium tuberculosis Complex

Received: April 05, 2017; Accepted: April 27, 2017; Published: April 29, 2017



1   Curto M, Reali C, Palmieri G, Scintu F, Schivo ML, et al. (2004) Inhibition of Cytokines Expression in Human Microglia Infected with Virulent  and  Nonvirulent  Mycobacteria.  Neurochem  Internat  44: 381-392.

2    Broxmeyer  L,  Sosnowska  D,  Miltner  E,  Chacón  O,  Wagner  D,  et al. (2002) Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J Infect Dis 186: 1155-1160.

3    Randall PJ, Hsu NJ, Lang D, Cooper S, Sebesho B, et al. (2014) Neurons are host cells for Mycobacterium tuberculosis. Infect Immun 82: 1880-1890.

4    Manuelidis  EE,  Manuelidis  L  (1989)  Suggested  Links  Between Different Types of Dementias: Creutzfeldt-Jakob disease, Alzheimer disease, and Retroviral CNS Infections. Alzheimer Dis Assoc Disord 3: 100-109.

5    Stockman S (1911) The habits of British ticks found on sheep and cattle. J Comp Pathol 24: 229-37.

6    Fischer O (1911) The spongious loss of the bones, a special process of destruction of the cerebral cortex. Z ges Neurol Psychiat 7: 1-33.

7   Babes V, Levaditi C (1897) On the Actinomycotic Shape of the Tuberculosis Bacilli (Sur la Forme Actinomycosique du Bacilli de la Tuberculosis). Arch of Med Exp et D’anat 9: 1041-1048.

8    Dunkin GW (1936) Paratuberculosis of Cattle and Sheep. Section of Comparative Medicine. Proc R Soc Med 30: 83-90

9    Chauveau A: Transmission of virulent diseases by the ingestion of virulent principles in the digestive tract. Gaz de Paris: p 45.

10  Klebs E (1870) On the history of tuberculosis. Virchows Arch F path Anat :p 291

11  Gerlach  AC  (1870)  On  the  inoculability  of  tuberculosis  and  the perilla, and on the transferability of the latter by feeding. Virchows Arch F path Anat 11: 297.

12  Pfeiffer DU (1994) The role of a wildlife reservoir in the epidemiology of bovine tuberculosis. Massey University, Dept of Veterinary Clinical Sciences, New Zealand.

13 Bourne J, Donnelly C (2001) An epidemiological investigation into bovine tuberculosis third report of the Independent Scientific Group on Cattle TB.

14  Francis  J  (1947)  Bovine  Tuberculosis:  Including  a  Contrast  with Human Tuberculosis. Staples Press Limited, London: p 220.

15  Taubes G (1986) The game of the name is fame. But is it science? Discover 7: 28-52.

16 Hadlow WJ, Prusiner SB, Kennedy RC, Race RE (1980) Brain tissue from persons dying of Creutzfeldt-Jacob disease causes scrapie-like encephalopathy in goats. Ann Neurol 8: 628-631.

17  Griffith JS (1967) Self-replication and scrapie. Nature 215: 1043-4.

18  Prusiner SB (1995) The  prion  diseases. Sci Am 272: 48-51.

19  Pethe K, Bifani P, Drobecq H, Sergheraert C, Debrie AS, et al. (2002) Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis. Proc Natl Acad Sci USA 2002 99: 10759-10764.

20  Tsubuki S, Takako Y (2003) Dutch,    Flemish,    Italian    and Arctic mutations of App and resistance of Abeta to physiologically relevant proteolytic degradation. Lancet 361: 1957-1958.

21  Lasmézas  CI,  Deslys  JP  (1997)  Transmission  of  the  BSE  agent to mice in the absence of detectable abnormal prion protein. Science 275: 402-405.

22  Baker  CA, Martin D, Manuelidis L (2002) Microglia from  Creutzfeld– Jakob disease-infected brains are   infectious and   show specific mRNA activation profiles. J Virol 76: 10905-10915.

23  Botsios S, Manuelidis L (2016) CJD and Scrapie Require Agent- Associated  Nucleic  Acids  for  Infection.  J  Cell  Biochem  117: 1947-1958.

24  Abalos P, Retamal P (2004) Tuberculosis: a re-emerging zoonosis? Rev Sci Tech 23: 583-94.

25  O’Reilly LM, Daborn CJ (1995) The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber Lung Dis 76: 1-46.

26  Grange JM (2001) Mycobacterium bovis infection in human beings. Tuberculosis 81: 71-77

27  Mattman LH (2001) Cell Wall Deficient Forms: Stealth Pathogens.CRC Press 3 (416).

28  Xalabarder C (1958) Electron microscopy of tubercle bacilli. Excerpta Medica. Sec XV Chest Dis 11: 467-473.

29  Xalabarder C (1963) The Nature of So-Called Atypical Mycobacteria. Neumol Cir Torax 24: 259-74.

30  Csillag A (1964) The mycococcus form of mycobacteria. Journ of Gen Microbio 34: 341-352

31  Shleeva  MO,  Salina  EG,  Kaprel’iants  AS  (2010)  Dormant  form  of Mycobacterium tuberculosis. Mikrobiologiia 79: 3-15

32  Zhang Y, Yang Y, Woods A, Cotter RJ, Sun Z (2001) Resuscitation of dormant Mycobacterium tuberculosis by phospholipids or specific peptides. Biochem Biophys Res Commun 284: 542-547.

33 Marcova N, Slavchev G, Michailova L (2012) Unique biological properties of Mycobacterium tuberculosis L-form variants: impact for survival under stress. Int. Microbiol 15: 61-68.

34  Shleeva MO, Mukamolova GV, Telkov MV, Berezinskaia TL, Syroeshkin AV et al. (2003) Formation of nonculturable Mycobacterium tuberculosis and their regeneration. Mikrobiologiia 72: 76-83.

35  Prusiner SB (2014) Madness and Memory: The Discovery of Prions – A New Biologic Principle of Disease. Yale University Press.

36  Hass G, Huntington R (1943) Amyloid. III The properties of amyloid deposits occurring in several species under diverse conditions. Arch Pathol 35: 226.

37 Schwartz P (1972) Amyloid degeneration and tuberculosis in the aged. Gerontologia 18: 321-362.

38 Delgado WA (1997) Amyloid deposits in labial salivary glands identified by electron microscopy. J Oral Pathol Med 26: 51-52.

39  de Beer FC, Nel AE (1984) Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis. Thorax 39: 196–200.

40  Tomiyama T, Satoshi A (1994) Rifampicin prevents the aggregation and neurotoxicity of amyloid B protein in vitro. Biochem Biophys Res Commun 204: 76-83.

41  Chauhan A, Madiraju MV, Fol M, Lofton H, Maloney E, et al. (2006) Mycobacterium  tuberculosis  Cells  Growing  in  Macrophages  Are Filamentous and Deficient in FtsZ Rings. J. Bacteriol 188: 1856-1865.

42 Markova N, Michailova L, Kussovski V, Jourdanova M (2008) Formation of Persisting Cell Wall Deficient Forms of Mycobacterium bovis BCG during Interaction with Peritoneal Macrophages in Guinea Pigs. Electronic Journal of Biology 4: 1-10

43 Thacore H, Willett HP (1966) The formation of spheroplasts of Mycobacterium tuberculosis in tissue culture cells. Am Rev Respir Dis 93: 786-796.

44 Lysenko AP, Vlasenko AP, Broxmeyer L (2014) Phenomenon of variability of mycobacteria and its use for detection of a tuberculosis infection.

45 Lysenko AP, Vlasenko VV, Broxmeyer L, Lemish AP, Novik TP, et al. (2014) The tuberculin skin test: how safe is safe?  The tuberculins contain unknown forms capable of reverting to cell-wall-deficient mycobacteria. Clinical and Experimental Medical Sciences 2: 55-73.

46  Lysenko  AP,  Broxmeyer  L,  Vlasenko  V,  Krasochko  PA,  Lemish  AP, et al. (2016) Further evidence for Cancer as Cell-wall-deficient Mycobacterial Disease. J Mol Pathol Epidemiol 1: 1-12.

47  Lysenko AP, Vlasenko VV, Lemish AP (2014) Detection of mycobacteria in tis- sues by means of the differentiating  immunoperoxidase staining. Tuberculos i bolezni legkhih. 10: 55-58.

48  Harry EJ (2001) Bacterial cell division: regulating Z-ring formation. Mol Microbiol 40: 795-803.

49  Errington J, Daniel RA, Scheffers DJ (2003) Cytokinesis in bacteria. Microbio Mol Biol Rev 67: 52-65.

50  Xalabarder C (1970) L-forms of chronic mycobacteria and nephritis. Publ Inst Antituberc(Barcelona) Supple 7:7-83.

51 Seidel B, Thomzig A, Buschmann A, Groschup MH, Peters R, et al. (2007) Scrapie agent (strain 263K) can transmit disease via the oral route after persistence in soil over years. PLoS One 2: e435.

52  Ghodbane R, Mba Medie F, Lepidi H, Nappez C, Drancourt M (2014) Long-term survival of tuberculosis complex mycobacteria in soil. Microbiology 160: 496-501.

53  Insanov AB, Gadzhiev FS (1996) Comparative Analysis of the Results of Spinal Fluid Microbiological Study in Children and Adults Who Suffered from Tuberculous Meningitis. Probl tuberk. 5: 25–28.

54  Slavchev  G,  Michailova  L,  Markova  N  (2013)  Stress-induced L-forms of M. bovis: challenge to survivability. New Microbiologica 36: 157-166.

55  Calmette A, Valtis J, Lacomme A (1928) New experimental research on tuberculous ultravirus. CR Acad Sci 186: 1778-1781.

56  Xiao X, Miravalle L, Yuan J, McGeehan J, Dong Z, et al. (2009) Failure to Detect the Presence of Prions in the Uterine and Gestational Tissues from a Gravida with Creutzfeldt – Jakob disease. Am J Pathol 174: 1602-1608.

57  Brieger EM (1949) The Host Parasite Relationship in Tuberculous Infection. Tubercle 30: 242-253.

58 Brieger EM, Glauert AM (1952) A Phase-Contrast Study of Reproduction in Mycelial Strains of Avian Tubercle Bacilli. J Gen Microbiol 7: 287-294.

59  Prusiner SB (2004) Development of the Prion Concept. Prion Biology and Diseases, Cold Spring Harbor Laboratory Press: pp 89-141.

60  Pattison IH (1988) Fifty years with scrapie: a personal reminiscence. Vet Rec 123: 661-666.

61  Pattison IH, Jones KM (1967) The possible nature of the transmissible agent of scrapie. Vet Rec 80: 7.

62  Gerston KF, Blumberg L, Tshabalala VA, Murray J (2004) Viability of mycobacteria in formalin-fixed lungs. Hum pathol 35: 571-575.

63  Vinnie DS, Mary R (2002) Does formaldehyde kill Myco tuberculosis? Tech Bull Histopath 2: 37-38.

64  Alzheimer A, Forstl H, Levy R (1991) On Certain Peculiar Diseases of Old Age. History of Psychiatry 2: 71-101.

65  Goedert M (2015) Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aß, tau and α-synuclein. Science 349: 1255555.

66 Schwab C, Hosokawa M, McGeer PL (2004) Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol 188: 52-64

67 Mawanda F, Wallace R (2013) Can infections cause Alzheimer’s disease? Epidemiol Rev 35: 161-80.

68  Alteri CJ, Xicahténcati-Cortes J, Hess S, Caballero-Olin G, Girón JA,et al. (2007) Mycobacterium Tuberculosis Produces Pili during Human Infection. Proc Natl Acad Sci USA 104: 5145-5150.

69 Jordal PB, Dueholm MS, Larsen P, Petersen SV, Enghild JJ, et al. (2009)  Widespread  abundance  of  functional  bacterial  amyloid in mycolata and other gram-positive bacteria. Appl Environ Microbiol 75: 4101-4110.



January 8, 2017



Broxmeyer L. Questioning the Zika
Virus. J Mol Path Epidemol. 2017, 1:1.

© Under License of Creative Commons Attribution 3.0 License


A growing body of health officials in Brazil are doubting that the Zika “virus” is responsible for the rise in birth defects in parts of that country. Zika, along with yellow fever, has been tossed into the family Flaviviruses; the Latin “flavus” meaning yellow. But unlike yellow fever, the vast majority of Zika’s symptoms for the last 70 years have been mild to non-existent. Despite disseminations by the lay and scientific press, there are serious questions whether Zika causes microcephaly at all. If by March, 2016 the Brazilian Ministry of Health reported 2,197 suspected cases of microcephaly, only 11.48% of these were Zika-positive. Zika is widespread throughout Brazil and South and Central America, yet the bulk of microcephaly cases are confined to the costal tip of Northeastern Brazil. Furthermore, despite extensive testing, no known mosquito-borne arbovirus or any other virus has to this point been proven to cause Brazilian microcephaly.

While Zika was being portrayed as “the most alarming health crisis to hit Brazil in decades”, tuberculosis and its related mycobacteria were quietly gaining a stranglehold and building an ecologic niche in the very Northeastern region being hit by epidemic microcephaly. Why was this important? With NE Brazilian microcephaly/Zika we are probably dealing with a mosquito-fueled environmental zoonosis – a disease that can be transmitted from animals to humans – such as primates, and to a lesser extent birds (Mycobacterium avium), and rodents (Mycobacterium microti), all mentioned in the Zika literature. Add to this the penchant of Brazilians to illegally capture and keep mycobacterial-laden wild monkies and exotic birds as pets or for revenue,and  you have a potential zoonotic time-bomb ready to explode once the proper vectors presents themselves. Three mosquito vectors have been steadily populating Northeastern Brazil: namely Culex quinquefasciatus, the Aedes aegypti and the Aedes albopictus – all of which have the capacity to transmit viral-like forms of the mycobacteria associated with HIV and through direct laboratory investigation with microcephaly. Perhaps it is time to rethink what’s really behind Brazilian Microcephaly and other symptomatology from the “Zika” agent.

KEYWORDS: The Zika virus; microcephaly; Aedes aegypti; Flaws in Zika diagnostics; Mycobacterium tuberculosis; Rhesus monkey; Brazil; CWD mycobacteria; Yellow fever; Flaviviruses; Systemic lupus erythmatosus; SLE; Neurtralization tests.

Received: October 07, 2016; Accepted: November 16, 2016; Published January 02, 2017


  1. Dick, G.W.A., Kitchen, S.F. and Haddow, A.J. (1952) Communications: Zika Virus—Isolations and Serological Specificity. Transactions of the Royal Society of Tropical Medicine and Hygiene, 46, 509-520.
  2. Bresalier, M, Mazumdar, P (ed.), Kroker, K (ed.) & Keelan, J (ed.) 2008, Neutralizing Flu: ‘Immunological devices’ and the making of a virus disease. in Crafting Immunity: Working Histories of Clinical Immunology. Ashgate, London, pp. 107-144.
  3. F.J. Fenner and R.V. Blanden, ‘History of Viral Immunology’, in A.L. Notkins (ed.), Viral Immunology and Immunopathology, New York, London: Academic Press, 1975, pp. 1–25 at pp.13–14.
  4. Van Helvoort T., “History of virus research in the 20th century: the problem of conceptual continuity”, History of Science 1994; 32(2):185-235
  5. Castets M, Boisvert H, Grumbach F, Brunel M, Rist N. Tuberculosis bacilli of the African type: preliminary note. Rev Tuberc Pneumol (Paris). 1968 Mar; 32(2):179-84.
  6. Broxmeyer, L, Kanjhan, R. (2016) Does Zika Really Have the Capacity to Affect the Nervous System and Cause Microcephaly or Intracranial Calcifications? Modern Research in Inflammation, 5, 20-30.
  7. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect 2014;20:O595-6.
  8. MacNamara FN. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg 1954; 48: 139-45.
  9. Fagbami AH. Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg (Lond) 1979; 83: 213-9.
  10.  Moore DL, Causey OR, Carey DE, et al. Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann Trop Med Parasitol 1975; 69: 49-64.
  11. Olson JG, Ksiazek TG, Suhandiman, Triwibowo. Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg 1981; 75: 389-93.
  12. Simpson DI. Zika virus infection in man. Trans R Soc Trop Med Hyg 1964; 58: 335-8.
  13. Zika virus: clinical evaluation and disease. Atlanta: Centers for Disease Control and Prevention
  14. Duffy MR, Chen T-H, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009; 360: 2536-43.
  15. Petersen LR, Jamieson DJ, Powers AM, and Honein MA. Zika Virus. N Engl J Med 2016; 374:1552-1563 April 21, 2016.
  16. Yamada S, Pobutsky A. Micronesian Migrant Health Issues in Hawaii: Part 1    Californian Journal of Health Promotion 2009, Volume 7, Issue 2, 16-31.
  17. Opening of Third STOP Tuberculosis in the Pacific. Monday, 31 July 2006. Press Release: Secretariat of the Pacific Community (SPC) Scoop Independent News.
  18. O’Hara CJ, Groopman JE. The ultrastructural and immunohistochemical demonstration of viral particles in lymph nodes from human immunodeficiency virus-related and nonhuman immunodeficiency virus-related lymphadenopathy syndromes. Hum Pathol. 1988; 19(5): 545–549.
  19. Nambuya A, Sewankambo N. Tuberculosis lymphadenitis associated with human immunodeficiency virus (HIV) in Uganda. J Clin Pathol. 1988; 41: 93–96.
  20. Voetberg A, Lucas SB. Tuberculosis or persistent generalized lymphadenopathy in HIV disease. Lancet. 1991; 337: 56–57.
  21. Bader JP. Reproduction of RNA humor viruses. Comprehensive Virol. 1975; 4: 253.
  22. Driggers RW, Ho CY, Korhonen EM, Kuivanen S, Jääskeläinen AJ et al. Brief Repot: Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities. N Engl J Med. 2016 Jun 2; 374(22):2142-51.
  23. Biedler JL et al. (1973) Morphology and growth, tumorgenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Research 33: 2643-2652
  24. Helson L et al. (1975) Human neuroblastoma in nude mice. Cancer Research 35: 2594-2599]
  25. Miller JM, Miller LD, Olson C, Gillette KG. Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J Natl Cancer Inst. 1969;43:1297–1305
  26. Alexander-Jackson, E. Microscopic and Submicroscopic Phases of P. Cryptocides from Fresh Lymphocytic leukemia. J Int Acad Metab 1978. 1:2:9-18
  27. Klieneberger-Nobel E. Origin, development and signifincance of L-forms in bacterial cultures. J Gen Microbiol 1949; 3: 434–442.
  28. Seibert FB, Feldman RL. Morphological, biological, and immunological studies on isolates from tumors and leukemic bloods. Ann NY Acad Sci. 1970; 174(2): 690–728.
  29. Mattman L. Cell Wall Deficient Forms—Stealth Pathogens. Boca Raton: CRC Press; 1993.
  30. Randall PJ, Hsu N-J, Lang D, et al. Neurons Are Host Cells for Mycobacterium tuberculosis. Appleton JA, ed. Infection and Immunity. 2014; 82(5):1880-1890
  31. FDA. Fact Sheet for Health Care Providers: Interpreting Zika Virus RNA Qualitative Real-Time RT-PCR Test Results. April 28th, 2016.
  32. Butler D. Zika and birth defects: what we know and what we don’t – Experts fear a major epidemic of Zika-linked birth defects, but can’t yet be sure. Nature. 21 March 2016.
  33. Good RC. Simian Tuberculosis: Immunological Aspects. Annals of the New York Acad of Sciences. September 1968. 154: 200-213.
  34. Johnson PDR, Azuolas J, Lavender CJ, Wishart E, Stinear TP, Hayman JA, et al. Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis. 2007 Nov. Available from
  35. Lavender CJ, Fyfe JAM, Azuolas J, Brown K, Evans RN, Ray LR, et al. (2011) Risk of Buruli Ulcer and Detection of Mycobacterium ulcerans in Mosquitoes in Southeastern Australia. PLoS Negl Trop Dis 5(9): e1305. doi:10.1371/journal.pntd.0001305.
  36. Banerjee, R., Banerjee, B.D., Chaudhury, S. and Hati, A.K. (1991) Transmission of Viable Mycobacterium leprae by Aedes aegypti from Lepromatous Leprosy Patients to the Skin of Mice through Intermittent Feeding. Tropical and Geographical Medicine, 42, 97-99.
  37. Narayanan, E., Manja, K.S., Kirchheimer, W.F. and Balasubrahmanyan, M. (1972) Occurrence of Mycobacterium leprae in Arthropods. Leprosy Review, 43, 194-198.
  38. Narayanan, E., Sreevatsa, Kirchheimer, W.F. and Bedi, B.M. (1977) Transfer of Leprosy Bacilli from Patients to Mouse Footpads by Aedes egypti. Leprosy Review, 49, 181-186.
  39. Narayanan, E., Sreevatsa, Raj, A.D., Kirchheimer, W.F. and Bedi, B.M. (1978) Persistence and Distribution of Mycobacterium leprae in Aedes egypti and Culex fatigans Experimentally Fed on Leprosy Patients. Leprosy in India, 50, 26-37.
  40. Golyshevskaya, V.I. (1991) The Role of Coccoid Ultrafine Forms of Mycobacteria in the Transmission of the Mycobacterial Infection. Pneumoftiziologia, 40, 11-13.
  41. Silva-Krott IM, Brock K, Junge RE. “Determination of the Presence of Mycobacterium avium on Guam as Precursor to Reintroduction of Indigenous Bird Species, Pacific Conservation Biology 4 (1998): 227–31.
  42. Smith M. WHO Raises Yellow Fever Warnings Urban outbreak in Angola might go global. MedPage.
  43. Manson P. Tropical Diseases. A Manual of the Diseases of Warm Climates. 1st edition. London: Cassell & Co.; 1898. p. 127.
  44. Lindenbach, BD et al. (2007). “Flaviviridae: The Viruses and Their Replication”. In Knipe, D. M.; P. M. Howley. Fields Virology (5th Ed.). Philadelphia, PA: Lippincott Williams & Wilkins. p. 1101
  45. Rivers TM. Filterable Viruses a Critical Review. From the Hospital of the Rockefeller Institute, New York Received for publication January 31, 1927 Journal of Bacteriology, Vol. XIV, No. 4; 217-257:220.
  46. Finlay C. The Mosquito Hypothetically Considered as the Transmitting Agent of Yellow Fever. Yale J Biol Med. 1937 Jul; 9(6): 589–604.
  47. Eckstein, Gustav. Noguchi. New York: Harper & Brothers, 1931 419pp
  48. Reed W. et al. The etiology of yellow fever. An additional note. J Amer Med Assoc. 1901; 36:431–440.
  49. Yellow fever. A compilation of various publications. Results of the work of Maj. Walter Reed, Medical Corps, United States Army, and the Yellow Fever Commission. 61st Congress, 3rd session. Senate Doc No 822. Washington: Government Printing Office; 1911.
  50. Del Regato, JA. James Carroll: a biography. Ann Diagn Pathol. 1998 Oct; 2(5):335-49.
  51. Kendall, AI. Observations Upon the Filterability of Bacteria, Including a Filterable Organism Obtained From Cases of Influenza. Science. August 7, 1931 74:1910.
  52. Krotz D. First Detailed Microscopy Evidence of Bacteria at the Lower Size Limit of Life. Berkeley Lab. February 27, 2015.
  53. Sternberg ML. George Miller Sternberg, A Biography. American Medical Association. Chicago. 1920. 331pp: p.118.
  54. Elliott CA. A clinical study of yellow fever: observations made in Guayaquil, Ecuador in 1918. Arch Intern Med (Chic). 1920;25(2):174-205
  55. Noguchi, H.: Etiology of Yellow Fever. J. Exper. M. 29:547, 1919; 30:1, 87, 401, 1919.
  56. Noguchi H. Etiology of yellow fever: II. Transmission experiments on yellow fever. J Exp Med. 1919; 29:565–584.
  57.  Noguchi H. Etiology of yellow fever: V. Properties of blood serum of yellow fever patients in relation to Leptospira icteroides. J Exp Med. 1919; 30:9–12.
  58. Stokes A, Bauer JH, Hudson N. The transmission of yellow fever to macacus rhesus: preliminary note. JAMA. 1928; 90(4):253-254.
  59. Mattman LH. Cell Wall Deficient Forms. CRC Press. Cleveland. 1974. 411 pp.
  60. Inada R, Ido Y, Hoki R, Kaneko R, and Ito H. The etiology, mode of infection, and specific therapy of Weil’s disease (Spirochaetosis Icterohaemorrhagica). J. Exp. Med., 23, 377-402. 1916.
  61. Hudson NP. Communication – Adrian stokes and yellow fever research: A tribute. Transactions of the Royal Society of Tropical Medicine and Hygiene.  60:2:170-174. 1966
  62. Letter from Noguchi to Simon Flexner, 1928 Noguchi’s papers. Record Group 450  N689 of the Rockefeller University Archives.;query=;brand=default;;doc.view=contents#aspace_ref36_m4i
  63. Extracts from letter of Hideyo Noguchi, Accra, March 9th, 1928 to Dr. Simon Flexner.;query=;brand=default;;doc.view=contents#aspace_ref36_m4i
  64. Received in NYC, NY Western Union Cablegram from Hideyo Noguchi to Dr. Simon Flexner March 16th, 1918 4/HN45C LCO  RUS  50.
  65. Noguchi to Russell of Rockefeller Institute  (Letter)  Accra  March 25, 1928.;query=;brand=default;;doc.view=contents#aspace_ref36_m4i
  66. Ekstein G. Hideyo Noguchi. Medical Bulletin College of Medicine University of Cincinnati, April, 1929. 5:3:15-17
  67. Jacob NJ, Henein SS. Nontuberculous Mycobacterial infection of the CNS in Patients with AIDS. Southern Medical Journal. Vol. 86 No. 6, 1993
  68. Bishburg E et al. Central Nervous System Tuberculosis with the Acquired Immunodeficiency Syndrome and Its Related Complex. Annals of Internal Medicine, 105: pp. 210-13.
  69. Lambertucci JR, Rayes AM, Nunes F, Landazuri-palacios EJ and Nobre V.  Fever of Undetermined Origin in Patients with the Acquired Immunodeficiency Syndrome in Brazil: Report on 55 Cases. Rev. Inst. Med. trop. S. Paulo Vol.41 N.1 São Paulo Jan./Feb. 1999
  70. Thomson, A. (1894) Microcephaly and Infantile Hemiplegia in the Journal of Anatomy and Physiology, Normal and Pathological, Human and Comparative. Humphray, G.M., Turner, W. and McKendrick, J.G., Eds., Vol. 28, Charles Griffin and Company, London, 419-444.
  71. Gluecksohn-Waelsch, S. (1957) The Effect of Maternal Immunization against Organ Tissues on Embryonic Differentiation in the Mouse. Journal of Embryology and Experimental Morphology, 5, 83-89.
  72. Warthin, A. S., and Cowie, D. M. A Contribution in the Casuistry of Placental and Congenital Tuberculosis. Journ. Inf. Dis., 1 (1904): 140.
  73. Rao, V. V., Gupta, E. V., and Thomas, I. M. Chromosome Damage in Untreated Tuberculosis Patients. Tubercle. 71, no. 3 (September 1990): 169–72.
  74. Lakimenko, L. N. Changes in the Mitotic Regime of a Cell Culture under the Influence of Sensitins. Biull Eksp Biol Med., 81, no. 2 (February 1976): 237–39.
  75. Golubchik, I. S., Lakimenko, L. N., and Lazovskaia, A. L. Effect of Tuberculin on the Mitotic Regime in Cell Cultures Biull Eksp Biol Med., 73, no. 5 (May 1972): 105–7.
  76. Nogales-Ortiz, F., and Tarancon, I. The Pathology of Female Genital Tuberculosis. Obstet. Gynecol., 53 (1979): 422-428.
  77. Favoretto S, Araujo D, Oliveira D, Duarte N, Mesquita F et al. First detection of Zika virus in neotropical primates in Brazil: a possible new reservoir. bioRxiv Apr 20, 2016  pp 1-3.
  78. Macdonald, David (Editor) (1985). Primates. All the World’s Animals. Torstar Books. pp. 1-50.
  79. Duarte-Quiroga, A; Estrada, A (2003). “Primates as pets in Mexico City: an assessment of the species involved, source of origin, and general aspects of treatment”. Am J Primatol 61: 53–60.
  80. Valderrama X, Robinson JG, Attygalle AB, Eisner T. (2000). “Seasonal Anointment with Millipedes in a Wild Primate: A Chemical Defense against Insects?” Journal of Chemical Ecology 26 (12): 2781–2790
  81. Michel AL, Huchzermeyer HF (1998) The zoonotic importance of Mycobacterium tuberculosis: Transmission from human to monkey. Journal of the South African Veterinary Association 69:64–65
  82.  Alfonso R, Romero RE, Diaz A, Calderon MN, Urdaneta G, Arce J, et al. (2004) Isolation and identification of mycobacteria in New World primates maintained in captivity. Veterinary Microbiology 98:285–295
  83. Capuano SV, Croix DA, Pawar S, Zinovik A, Myers A, Lin PL, et al. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infection and Immunity. 2003; 71:5831–5844
  84. Une, Y. and Mori, T., “Tuberculosis as a zoonosis from a veterinary perspective”, Comp. Immunol. Microb. 2007 Sep; 30(5-6):415-425,
  85. Okia NO, George PV, Tukei PM, Kafuko GW, Lule M, Sekyalo E, et al. Arbovirus survey in wild birds in Uganda. East Afr Med J. 1971; 48(12):725–31. PMID: 5148604
  86. Spinage CA. African Ecology – Benchmarks and Historical Perspectives. Springer Science & Business Media. Jan 28, 2012 1562pp:  p.1124
  87. Garmany, Jeff (2011). Situating Fortaleza: Urban space and uneven development in northeastern Brazil Cities (Elsevier) 28 (1): 45–52
  88. Ranking das maiores regiões metropolitanas do Brasil. 10/12/2010
  89. NatureServe. InfoNatura: birds, mammals, and amphibians of Latin América (Web application). 32nd edition. Arlington, Virginia. NatureServe. 2010.
  90. Marini MA, Garcia FI: Bird conservation in Brazil. Conservation Biology 2005, 19(3):665–671
  91. Alves RRN, Lima JRF, Araújo HF: The live bird trade in Brazil and its conservation implications: an overview. Bird Conservation International 2012.
  92. Alves RRN, Nogueira E, Araujo H, Brooks S: Bird-keeping in the Caatinga, NE Brazil. Hum Ecol 2010, 38(1):147–156.
  93. Gama TF, Sassi R: Aspectos do comércio Ilegal de Pássaros Silvestres na Cidade de João Pessoa, Paraíba, Brasil. Gaia Scientia 2008, 2(2):1–20.
  94. Silva JMC, Souza MA, Bieber AGD, Carlos CJ. Aves da Caatinga: Status, uso do habitat e sensitividade. In: Ecologia e Conservação da Caatinga. 1st Edition. Edited by Leal IR, Tabarelli M, Silva JMC. Recife, Brasil. Universitária da UFPE; 2003:237–274
  95. Fernandes-Ferreira H, Mendonça SV, Albano C, Ferreira FS, Alves RRN: Hunting, use and conservation of birds in Northeast Brazil. Biodivers Conserv. 2012, 21: 221-244.
  96. Dhama, K., Mahendran, M., Tiwari, R., Dayal Singh, S., Kumar, D., Singh, S., & Sawant, P. M. (2011). Tuberculosis in Birds: Insights into the Mycobacterium avium Infections. Veterinary Medicine International, 2011, 712369.
  97. Marx, F. (2011) Tuberculosis in the Region of the Americas – Regional Report 2011: Epidemiology, Control and Financing. Pan-American Health Organization, Regional Office of the World Health Organization. Washington DC, 53pp
  98. Starke JR, Jacobs RF, Jereb J. Review: Resurgence of tuberculosis in children. J  Pediatr. 1992 Jun; 120(6):839-55
  99. Melo, A.S.O., Malinger, G., Ximenes, R., Szejnfeld, P.O., Sampaio, S.A. and Bispo de Filippis, A.M. (2016) Zika Virus Intrauterine Infection Causes Fetal Brain Abnormality and Microcephaly: Tip of the Iceberg? Ultrasound in Obstetrics & Gynecology, 47, 6-7.
  100. Anga G, Barnabas R, Kaminiel O, Tefuarani Vince NJ, Ripa P, Riddell M and Duke T. The aetiology, clinical presentations and outcome of febrile encephalopathy in children in Papua New Guinea. Annals of Tropical Paediatrics 2010, Jun 21. 30(2): 109-18.
  101. Zika Virus in Papua New Guinea. Centers for Disease Control and Prevention (CDC); National Center for Emerging and Zoonotic Infectious Diseases (NCEZID); Division of Global Migration and Quarantine (DGMQ). Last updated: April 29, 2016
  102. There is no outbreak of Zika virus in PNG. Press release: PORT MORESBY (POST COURIER) March 21, 2016]
  103. Eccles, G. Papua New Guinea’s Tuberculosis Pandemic. March 28, 2016 The Diplomat
  104. Koch R., “Die Ätiologie der Tuberkulose” (“The Aetiology of Tuberculosis”), Mitteilungen aus dem Kaiserlichen Gesundheitsamte 1884; 2:1-88.
  105. Zika travel information. Atlanta: Centers for Disease Control and Prevention, January 2016
  106. Gourinat AC, O’Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M. Detection of Zika virus in urine. Emerg Infect Dis 2015; 21:84-86.
  107. Korhonen EM, Huhtamo E, Smura T, Kallio-Kokko H, Raassina M, Vapalahti O. Zika virus infection in a traveller returning from the Maldives, June 2015. Euro Surveill 2016; 21.
  108. Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau VM. Potential sexual transmission of Zika virus. Emerg Infect Dis 2015; 21:359-361.
  109. Foy BD, Kobylinski KC, Chilson Foy JL, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis 2011; 17:880-882.
  110. McCarthy M. Zika virus was transmitted by sexual contact in Texas, health officials report. BMJ 2016; 352: i720-i720.
  111. Venturi G, Zammarchi L, Fortuna C, et al. An autochthonous case of Zika due to possible sexual transmission, Florence, Italy, 2014. Euro Surveill 2016;21.
  112. Transmission of Zika virus through sexual contact with travelers to areas of ongoing transmission — continental United States, 2016. MMWR Morb Mortal Wkly Rep 2016; 65:215-216.
  113. Zika virus infection: global update on epidemiology and potentially associated clinical manifestations. Wkly Epidemiol Rec 2016;91:73-81.
  114. Lauritsen J. Has Provincetown Become Protease Town? [Internet]. Available from:
  115. Hellyer TJ, Desjardin LE, Teixeira L, Perkins MD, Cave MD, Eisenach KD. Detection of Viable Mycobacterium tuberculosis by Reverse Transcriptase-Strand Displacement Amplification of mRNA. Clin. Microbiol. March 1999. 37:3:518-523.
  116. Cáceres M. Birth of the Zika Industry. The Vaccine Reaction. May 16, 2016.
  117. Centers for Disease Control and Prevention. CDC Concludes Zika Causes Microcephaly and Other Birth Apr. 13, 2016.
  118. Centers for Disease Control and Prevention (CDC). Zika Virus. Clinical evaluation and disease. April 19, 2016
  119. Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL et al. Harrison’s Principles of Internal Medicine 16th Edition (July 23, 2004), McGraw-Hill Professional. 2607 p.
  120. Klase ZA, Khakhina S, Schneider ADB, Callahan MV, Glasspool-Malone J, Malone R (2016) Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome. PLoS Negl Trop Dis 10(8).
  121. Schlossberg D. Clinical Infectious Disease. Cambridge University Press. Apr 23, 2015. 1508pp p.481
  122. Cantwell AR Jr, Kelso DW, Jones JE. Histologic observations of coccoid forms suggestive of cell wall deficient bacteria in cutaneous and systemic lupus erythematosus. Int J Dermatol. 1982 Nov; 21(9):526-37.
  123. Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N,et al. Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 2008; 8:24-8.
  124. Ghosh K, Patwardhan M, Pradhan V. Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas. Rheumatol Int 2009; 29:1047-50.
  125. Purice S, Mitu S, Popescu T, Guran M, Vintilă M, Suţă G. The relationship between systemic lupus erythematosus and tuberculosis. Med Interne 1982; 20:191-6
  126. Prabu VNN, Agrawal S. Systemic lupus erythematosus and tuberculosis: A review of complex interactions of complicated diseases. Journal of Postgraduate Medicine 56, Num. 3, 2010, pp. 244-250.
  127. Zika Virus RNA Qualitative Real-Time RT-PCR. Focus Diagnostics, Inc. For use under an Emergency Use Authorization only Instructions for Use.
  128. R. Nowell, “Comparative Mosquito Collection Data from the Southern Mariana Islands (Diptera: Culicidae),” Proceedings of the California Mosquito and Vector Control Association 48 (1980): 112–6.
  129. Flexner, S. Simon Flexner Papers, 1891-1946. Noguchi to Flexner Aug. 11, 1924. Rockefeller Archive Center.
  130. Mlakar, J., Korva, M., Tul, N., et al. (2016) Brief Report: Zika Virus Associated with Microcephaly. New England Journal of Medicine, 374, 951-958.
  131. Rubin, E.J., Greene, M.F. and Baden, L.R. (2016) Editorial: Zika Virus and Microcephaly. New England Journal of Medicine, 374, 984-985.]
  132. The Pan American Health Organization/World Health Organization (PAHO/WHO). Epidemiological Update. Zika virus infection. 16 October 2015.























Further Evidence for Cancer as a Cell-Wall-Deficient Mycobacterial Disease

December 5, 2016

A.P. Lysenko PhD, L. Broxmeyer MD, V.V. Vlasenko PhD, P.A. Krasochko PhD, A.P.Lemish PhD, and E.A. Krasnikova

Further Evidence for Cancer as a Cell-Wall-Deficient Mycobacterial Disease.pdf

Corresponding author:
Lawrence Broxmeyer, M.D

© Under License of Creative Commons Attribution 3.0 License


Received: October 07, 2016; Accepted: November 03, 2016; Published: November
14, 2016



In 2014, Buehring reported that Bovine Leukemic Virus (BLV), a common oncogenic retrovirus of cattle, was present in some humans, primarily localized to the breast epithelium  ―  the  very  cell  type  from  which  most  breast  malignancies  arise.  By 2015, there appeared data (Buehring, 2015) supporting that as many as 37% of human breast cancer cases could be attributable to BLV exposure. But if recent estimates suggest over 83% of U.S. dairy operations are currently positive for BLV, they also show that approximately 68% are positive for cell-wall-deficient Mycobacterium avium subspecies paratuberculosis (MAP). Although tubercular lung infection has been said to cause 11 times the incidence of lung cancer as normal control subjects, it is its cell-wall-deficient (CWD) forms (also called L-forms) that have recently repeatedly been found through genetic analysis and appropriate stains in such cancer tissue ― suggesting that CWD tuberculosis or atypical tuberculosis “is likely to be involved in the occurrence or development of lung carcinoma”. A similar relationship between tubercular L-forms and the genesis of the very breast cancer addressed in the aforementioned BLV viral trials. This is not a coincidence. L-forms (CWD forms) predominate and are crucial to the survival of mycobacteria in vivo and they have been documented by fluorescence microscopy in all intracellular macrophage-grown M. tuberculosis observed. From its origin, the very concept of the “BLV leukemic virus” has been on shaky, unstable ground. In 1969, veterinarians Janice and Lyle Miller from the University of Wisconsin-Madison spotted C-shaped “virus-like” particles in cattle lymphosarcoma insisting that these were similar to other C-type viruses “regarded as the cause of leukemia in other species.” But by 1978, scientists at Downstate reported atypical mycobacterial forms, including its preferred filterable virus-sized “L” or cell-wall-deficient (CWD) forms in not only leukemia but all other malignancies ― all having, as their common denominator the continuous presence of mycobacterial C-shaped forms.

Tracing back to techniques similar to Miller and Millers original BLV study we found in the very lyophilized antigens present in commercial kits for the diagnosis of BLV (AgBLV), these very same CWD (cell-wall-deficient) mycobacteria and mycobacterial DNA in all BLV samples ― which when introduced into guinea pigs stimulated the same antibody as occurred when mycobacteria-infected internal organ homogenates themselves were injected into other guinea pigs. It is therefore assumed that the Bovine Leukemic Virus (BLV) is being mistaken for viral-like forms of cell-wall-deficient (CWD) atypical tubercular mycobacteria. Since latent tubercular infection, as well as the administration of BCG and tuberculin also results in persistent CWD forms, their possible role in carcinogenesis is also considered.

KEYWORDS: Cancer; Mycobacterium tuberculosis; Bovine Leukemic Virus; BLV; Mycobacteriophages



1   Rous PA (1911) Sarcoma of the fowl transmissible by an agent separable from the tumour cells. J Exp Med 13: 397-411.

2    Bittner JJ (1936) Some possible effects of nursing on the mammary gland tumour incidence of mice. Science 84: 162.

3    Van Helvoort T (1994) History of virus research in the 20th century: the problem of conceptual continuity. History of Science 32: 185-235.

4    Livingston V (1972) Cancer: A New Breakthrough. Nash Publishing p: 269.

5  Livingston V (1970) Specific type of organism cultured from malignancy: bacteriology and proposed classification.  Ann NY Acad Sci 174: 636-654.

6    Duran-Reynals F (1950) Neoplastic infection and cancer. Am J Med 8: 440-511.

7    Glover T, Scott MA (1926) Study of the Rous chicken sarcoma no 1. Canada Lancet Pract 66: 49-62.

8    Diller I (1970) Experiments with mammalian tumor isolates. Ann NY Acad Sci 174: 655-674.

9    Miller JM, Miller LD, Olson C, Gillette KG (1969) Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J Natl Cancer Inst 43: 1297-1305

10 Miller JM (1974) Animal model of human disease. Malignant lymphoma. Am J Pathol 75: 417-420.

11  Sorensen DK, Dutta SK, Hammer RF, Larson VL, Perman V, et al. (1970) Bovine lymphocytic leukemia: studies of etiology, pathogenesis and mode of transmission. Progress Report no. 10 to the U.S. Atomic Energy Commission, 1969-1970 p: 38

12  Alexander-Jackson EA (1954) specific type of microorganism isolated from animal and human cancer: bacteriology of the organism. Growth 18: 37-51.

13  Klieneberger-Nobel E (1949) Origin, development and significance of L-forms in bacterial cultures. J Gen Microbiol 3: 434-442.

14  Mattman LH (2000) Cell wall deficient forms: stealth pathogens. CRC Press.

15  Kashala O, Marlink R, Ilunga M, Diese M, Gormus B, et al. ( 1994) Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. J Infect Dis 169: 296-304.

16  Glover T (1930) The bacteriology of cancer. Canada Lancet Pract 75: 92-111.

17  Mazet G (1941) Etude Bacteriologique sur la Maladie d’ Hodgkin. Montpellier Med pp: 1-6.

18  Livingston V, Allen R (1948) Presence of consistently recurring invasive myco- bacterial forms in tumor cells. Microscop Soc Bull 2: 5-18.

19  Wuerthele-Caspe V (1949) Mycobacterial forms observed in tumors. J Am Med. Womens Assoc 4: 135-141.

20  Alexander-Jackson  E  (1976)  Progenitor  Cryptocides,  The  Specific Pleomorphic Microorganism Isolated From Cancer. J Int Acad Metab 5: 31-39.

21  Alexander-Jackson E (1978) Microscopic and Submicroscopic Phases of P. Cryptocides from Fresh Lymphocytic leukemia. J Int Acad Metab 1: 9-18.

22  Diller I, Diller W (1965) Intracellular acid-fast organisms isolated from malignant tissues. Trans Am Micr Soc 84: 138-148.

23  Diller I, Donnelly A, Fisher M (1967) Isolation of pleomorphic, acid- fast organisms from several strains of mice. Cancer Res 27: 1402-1408.

24 Seibert F, Feldmann F, Davis R, Richmond I (1970) Morphological, biological, and immunological studies on isolates from tumors and leukemic bloods. Ann N Y Acad Sci 174: 690-728.

25  Wang A, Xie J (1998) Infection of mycobacterium tuberculosis in lung cancer. Zhongguo Fei Ai Za Zhi 1: 92-94.

26  Guliang  H,  Tefu  L  (1999)  Mycobacterium  tuberculosis  L-forms. Microb Ecol Health Dis 10: 129-133.

27  Xie J, Anchao W, Xiazhi Z (1999) Isolation of acid fast bacillus L- forms from carcinoma of Lung. Acta Academiae Medicinae Bengbu 24: 145-146.

28 Song LY, Yan WS, Zhao T (2002) Detection of Mycobacterium tuberculosis in lung cancer tissue by indirect in situ nested PCR. Di Yi Jun Yi Da Xue Xue Bao 22: 992-993.

29 Yesong WXQ , Lifa X (2004)   A case report on pneumoconiotu- berculosis complicated with lung cancer and   Mycobacterium tuberculosis- L form infection. Chin J Industrial Med.

30 Zhang  S,  Guang-ling  Z,  Yan-sheng  T  (2009)  Detection  of Mycobacterium tuberculosis L forms infection in tissues of lung carcinoma. Chin J Public Health 25: 1317-1318.

31 Yang B, Tian Y, Cui X, Zhang W, Ma Y et al. Detection of Mycobacterium tuberculosis L-forms and MPB64 in breast cancer tissues The Journal of Practical Medicine. 2013; 29(15) p2552-2555.

32  Sheng TY, Kun CX, Tong H, Guang LH, Wei Z, et al. (2009) Study on the relationship between Mycobacterium tuberculosis L infection and lung cancer. Tumor 29: 1085-1089.

33  Tian Y, Hao T, Cao B, Zhang W, Ma Y, et al. (2015) Clinical End-Points Associated with Mycobacterium tuberculosis and Lung Cancer: Implications into Host- Pathogen Interaction and    Coevolution. Bio Med Research Intern p: 9.

34 Alexander-Jackson E (1970) Ultraviolet spectrogramic microscope studies of Rous sarcoma virus cultured in cell-free medium. Ann N Y Acad Sci 174: 765-781.

35  Van der Maaten M, Miller J (1976) Replication of bovine leukemia virus in monolayer cell cultures. Bibl Haemat 43: 360-362.

36  Lysenko  AP,  Drogun  AG,  Shurinova  (1998)  Studies  of  influence atypical mycobacterial  infection on AGID results with sera of cattle infected BLV (in Russian). Vet. nauka – proizvodstvu 33: 56-54.

37  ShivRaj L, Patil SA, Girdhar A, Sengupta U, Desikan KV, et al. (1988) Antibodies to HIV-1 in sera from patients with mycobacterial infections. Int J Leprosy 56: 546-551.

38 Lysenko AP, Vlasenko AP, Broxmeyer L (2014) Phenomenon of variability of mycobacteria and its use for detection of a tuberculosis infection.

39 Lysenko AP, Vlasenko VV, Broxmeyer L, Lemish AP, Novik TP, et al. (2014) The tuberculin skin test: how safe is safe?  The tuberculins contain unknown forms capable of reverting to cell-wall deficient mycobacteria. Clin Exp Med Sci 2: 55-73.

40  Lysenko AP, Vlasenko VV, Lemish AP (2014) Detection of mycobacteria in tissues by means of the differentiating immunoperoxidase staining. Tuberculos i bolezni legkhih 10: 55-58.

41  Duesberg PH (1987)  Retroviruses  as carcinogens and pathogens: expectations and reality. Cancer Res 47: 1199-220.

42  Demochowski L, Grey CE (1957) Subcellular Structures of Possible Viral Origin in Some Mammalian Tumors. Ann NY Acad Sci : pp 559-615

43 Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.

44  Dameshek W and Gunz (1965) Leukemia. Am J Med Sci 249: 115.

45 Seibert  FB,  Feldmann  PM,  Davis  RL,  Richmond  IS  (1970) Morphological, Biological, and Immunological Studies on Isolates from Tumors and Leukemic Bloods. Ann NY Acad Sci 174: 690-728.

46 Mankiewicz E (1965) Bacteriophages that lyse mycobacteria and corynebacteria, and show cytopathogenic effect on tissue cultures of renal cells of cercopithecus aethiops: a preliminary communication. Can Med Assoc J 92: 31-33.

47  Seibert FB (1968) Pebbles on the hill of a scientist. St Petersburg Printing Company 1: 162.

48 Dobrindt U, Reidl J (2000) Pathogenicity islands and phage conversion: evolutionary aspects of bacterial pathogenesis. Int J Med Microbiol 290: 519-27.

49 Landman OE, Burchard WK, Angelety LH (1962) Lysogeny and bacteriophage adsorption in stable and reverting L-forms of Salmonella paratyphi B and Escherichia coli. Bacteriol Proc p: 53.

50  Falagas ME, Kouranos VD, Athanassa Z, Kopterides P (2010) Review ―Tuberculosis and malignancy. Q J Med 103: 461-487.

51  Nelson EL, Pickett MJ (1951) The Recovery of L Forms of Brucella and their Relation to Brucella Phage. J Infect Dis 89: 226-32.

52  Kruegar AP, Cohn T, Smith PN, McGuire CD (1948) J Gen Physiol 31: 477-488.

53 Takahashi S (1979) L phase growth of Mycobacteria. 1. Cell wall deficient form of Mycobacteria. Kekkaku 54: 63-70.

54  Broxmeyer L, Sosnowska  D,  Miltner E, Chacón O, Wagner D, et al. (2002) Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J Infect Dis 186: 1155-60.

55 Devadoss PO, Klegerman ME, Groves MJ (1993) Phagocytosis of Mycobacterium bovis BCG organisms by murine S180 sarcoma cells. Cytobios 74: 49-58.

56 Marcova N, Michailova L, Kussovsski V, Jordanova M (2008) Formation of persisting Cell Wall Deficient Forms M. bovis BCG during interaction with peritoneal macrophages in guinea pigs. Electronic J. of Biology 4: 1-10.

57  Chauhan A, Madiraju MV, Fol M, Lofton H, Maloney E, et al. (2006) Mycobacterium tuberculosis Cells Growing in Macrophages Are Filamentous and Deficient in FtsZ Rings. J Bacteriol 188: 1856-1865

58  Wagner PL, Waldor MK (2002) Bacteriophage Control of Bacterial Virulence. Infect Immun 70: 3985-3993.